Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement
Original Research | By L Faroux , E Munoz-Garcia, J Rodes-Cabau et al.
BACKGROUND - Scarce data exist on coronary events following transcatheter aortic valve replacement (TAVR), and no study has determined the factors associated with poorer outcomes in this setting. This study sought to determine the clinical characteristics, outcomes, and prognostic factors of acute coronary syndrome (ACS) events following TAVR. METHODS - Multicenter cohort study including a total of 270 pa...
Review Article | By GWM Wijntjens , EL van Uffelen, TP van de Hoef et al.
BACKGROUND - Intravenous infusion of adenosine is considered standard practice for fractional flow reserve (FFR) assessment but is associated with adverse side-effects and is time-consuming. Intracoronary bolus injection of adenosine is better tolerated by patients, cheaper, and less time-consuming. However, current literature remains fragmented and modestly sized regarding the equivalence of intracoronary versus intravenous adenosin...
Routine Continuous Electrocardiographic Monitoring Following Percutaneous Coronary Interventions
Original Research | By MA Al-Hijji , R Gulati,M Singh et al.
BACKGROUND - The clinical utility of routine electrocardiographic monitoring following percutaneous coronary interventions (PCI) is not well studied. METHODS - We prospectively evaluated the incidence, cost, and the clinical implications of actionable arrhythmia alarms on telemetry monitoring following PCI. One thousand three hundred fifty-eight PCI procedures (989 [72.8%] for acute coronary syndr...
ACC Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19)
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy
Clinical Trial | By U Baber, MU Zafar, R Mehran et al.
BACKGROUND - An evolving strategy in the setting of percutaneous coronary intervention (PCI) involves withdrawal of acetylsalicylic acid (ASA), or aspirin, while maintaining P2Y12 inhibition. However, the pharmacodynamic effects of this approach on blood thrombogenicity and platelet reactivity remain unknown. OBJECTIVES - This study sought to compare the antithrombotic potency of ticagrelor a...
Original Research | By Satoru Suzuki , K Kaikita, E Yamamoto et al.
Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure
Original Research | By DT Ko, R Khera, G Lau et al.
BACKGROUND - Readmission rates after acute myocardial infarction (AMI) and heart failure (HF) hospitalizations have decreased in the United States since the implementation of the Hospital Readmissions Reduction Program. OBJECTIVES - This study was designed to examine the temporal trends of readmission and mortality after AMI and HF in Ontario, Canada, where reducing hospital readmissions h...
Original Research | By G Witberg, BD Bruyne, WF Fearon et al.
OBJECTIVES - This study sought to assess the diagnostic performance of FFRangio (CathWorks, Kfar Saba, Israel), an angiogram-derived fractional flow reserve (FFR) technology. BACKGROUND - Despite practice guidelines recommendations, the use of coronary physiologic assessment in daily practice remains low for patients undergoing coronary angiography. Angiogram-derived FFR technologies have ...
Original Research | By E Van Belle , F Vincent , J Labreuche et al.
BACKGROUND - No randomized study powered to compare balloon expandable (BE) with self expanding (SE) transcatheter heart valves (THVs) on individual end points after transcatheter aortic valve replacement has been conducted to date. METHODS - From January 2013 to December 2015, the FRANCE-TAVI nationwide registry (Registry of Aortic Valve Bioprostheses Estab...